JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
+6.87%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$167M
AUM Growth
+$167M
(+5.8%)
Cap. Flow
+$5.74M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
89.11%
Holding
67
New
16
Increased
7
Reduced
24
Closed
12
Top Buys
| 1 |
Boyd Gaming
BYD
|
$64.3M |
| 2 |
Nu Holdings
NU
|
$11.7M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
$6.99M |
| 4 |
Incyte
INCY
|
$1.18M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$1.02M |
Top Sells
| 1 |
Mercado Libre
MELI
|
$18.9M |
| 2 |
StoneCo
STNE
|
$16.6M |
| 3 |
Sigma Lithium
SGML
|
$11.6M |
| 4 |
XP
XP
|
$10.8M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
$4.96M |
Sector Composition
| 1 | Consumer Discretionary | 38.57% |
| 2 | Financials | 26.51% |
| 3 | Healthcare | 11.54% |
| 4 | Materials | 3.69% |
| 5 | Energy | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Boyd Gaming
BYD
$6.88B
| $64.3M | 38.57% | +300,000 | New | +$64.3M |
|
|
2
Nu Holdings
NU
$71.5B
| $24.8M | 14.88% | 2,977,959 +1,406,372 | +89% | +$11.7M |
|
|
3
XP
XP
$9.56B
| $18.6M | 11.15% | 713,164 -413,749 | -37% | -$10.8M |
|
|
4
iShares MSCI Brazil ETF
EWZ
$5.45B
| $6.99M | 4.19% | +200,000 | New | +$6.99M |
|
|
5
Sigma Lithium
SGML
$747M
| $5.86M | 3.51% | 185,767 -368,843 | -67% | -$11.6M |
|
|
6
Incyte
INCY
$16.5B
| $1.97M | 1.18% | 31,306 +18,849 | +151% | +$1.18M |
|
|
ONC
7
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.78M | 1.06% | 9,845 +5,665 | +136% | +$1.02M |
|
8
UnitedHealth
UNH
$281B
| $1.65M | 0.99% | 3,126 -10 | -0.3% | -$5.27K |
|
9
Eli Lilly
LLY
$657B
| $1.36M | 0.82% | 2,339 -7 | -0.3% | -$4.08K |
|
10
VanEck Gold Miners ETF
GDX
$19B
| $1.31M | 0.78% | 42,184 +16,601 | +65% | +$515K |
|
11
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.13M | 0.68% | 36,110 +19,757 | +121% | +$619K |
|
12
Thermo Fisher Scientific
TMO
$186B
| $994K | 0.6% | 1,873 -6 | -0.3% | -$3.19K |
|
13
Intuitive Surgical
ISRG
$170B
| $724K | 0.43% | 2,146 -7 | -0.3% | -$2.36K |
|
14
Regeneron Pharmaceuticals
REGN
$61.5B
| $718K | 0.43% | 817 -2 | -0.2% | -$1.76K |
|
15
Merck
MRK
$210B
| $673K | 0.4% | 6,175 -20 | -0.3% | -$2.18K |
|
16
AstraZeneca
AZN
$248B
| $658K | 0.39% | 9,766 -31 | -0.3% | -$2.09K |
|
17
Danaher
DHR
$147B
| $652K | 0.39% | 2,819 -9 | -0.3% | -$2.08K |
|
18
Vertex Pharmaceuticals
VRTX
$100B
| $607K | 0.36% | 1,492 -5 | -0.3% | -$2.03K |
|
19
Elevance Health
ELV
$71.8B
| $561K | 0.34% | 1,189 -4 | -0.3% | -$1.89K |
|
20
Stryker
SYK
$150B
| $540K | 0.32% | 1,804 -6 | -0.3% | -$1.8K |
|
21
S&P Global
SPGI
$167B
| $485K | 0.29% | +1,100 | New | +$485K |
|
22
Humana
HUM
$36.5B
| $380K | 0.23% | 831 -2 | -0.2% | -$916 |
|
23
argenx
ARGX
$43.6B
| $379K | 0.23% | 996 -279 | -22% | -$106K |
|
24
Agilent Technologies
A
$35.7B
| $367K | 0.22% | 2,642 -9 | -0.3% | -$1.25K |
|
25
Alnylam Pharmaceuticals
ALNY
$58.5B
| $354K | 0.21% | 1,850 -6 | -0.3% | -$1.15K |
|